PATH | VRL
Menu
We've moved! Same resources, new address: vaccineresources.org

Find resources

Total results with these characteristics: 178

Disease: Human papillomavirus (HPV)

Page 8 of 9
Safety Profile of the 9-Valent HPV Vaccine: A Combined Analysis of 7 Phase III Clinical Trials

This article, published in Pediatrics, evaluated the overall safety profile of the 9-valent human papillomavirus (9vHPV) vaccine across seven Phase 3 studies in 9 to 26 year old males and females (nonpregnant at entry). The authors found that the …

Author: Moreira ED, Block SL, Ferris D, et al.

Publication date: 2016

A School-Based Human Papillomavirus Vaccination Program in Barretos, Brazil: Final Results of a Demonstrative Study

This article, published in PLoS ONE, reports on a study to evaluate the uptake and three-dose completion rates of a school-based human papillomavirus (HPV) vaccination program in Brazil. The results showed high rates of vaccination uptake and …

Author: Fregnani JHTG, Carvalho AL, Eluf-Neto J, et al.

Publication date: 2013

Shaping a Strategy to Introduce HPV Vaccines in India—Formative Research Results From the HPV Vaccines: Evidence for Impact Project

This report summarizes results from formative research in two states of India—Andhra Pradesh and Gujarat—regarding the health systems and policy context that will affect human papillomavirus (HPV) vaccine introduction, as well as …

Author: PATH

Publication date: 2009

Shaping a Strategy to Introduce HPV Vaccines in Peru—Formative Research Results From the HPV Vaccines: Evidence for Impact Project

This report summarizes results from formative research in Peru regarding the health systems and policy context that will affect human papillomavirus (HPV) vaccine introduction, as well as beliefs, values, attitudes, knowledge, and behaviors related …

Author: PATH

Publication date: 2009

Shaping a Strategy to Introduce HPV Vaccines in Uganda—Formative Research Results From the HPV Vaccines: Evidence for Impact Project

This report summarizes results from formative research in Uganda regarding the health systems and policy context that will affect human papillomavirus (HPV) vaccine introduction, as well as beliefs, values, attitudes, knowledge, and behaviors …

Author: PATH

Publication date: 2009

Shaping a Strategy to Introduce HPV Vaccines in Vietnam—Formative Research Results From the HPV Vaccines: Evidence for Impact Project

This report summarizes results from formative research in Vietnam regarding the health systems and policy context that will affect human papillomavirus (HPV) vaccine introduction, as well as beliefs, values, attitudes, knowledge, and behaviors …

Author: PATH

Publication date: 2009

Significantly Reduced Genoprevalence of Vaccine-Type HPV-16/18 Infections Among Vaccinated Compared to Non-Vaccinated Young Women 5.5 Years After a Bivalent HPV-16/18 Vaccine (Cervarix®) Pilot Project in Uganda

This article, published in PLoS ONE, reports the results of a study that analyzed the prevalence of vaccine and non-vaccine types of human papillomavirus (HPV) infections among bivalent HPV vaccinated and non-vaccinated women aged 15 to 24 years in …

Author: Kumakech E, Berggren V, Wabinga H, et al.

Publication date: 2016

Social Mobilisation, Consent and Acceptability: A Review of Human Papillomavirus Vaccination Procedures in Low and Middle-Income Countries

This article, published in BMC Public Health, reports on a study that synthesized experiences and lessons learned around social mobilization, consent, and acceptability during 55 human papillomavirus (HPV) vaccine demonstration projects in 37 low- …

Author: Kabakama S, Gallagher KE, Howard N, et al.

Publication date: 2016

Sociocultural Issues in the Introduction of Human Papillomavirus Vaccine in Low-Resource Settings

This article, published in Archives of Pediatrics & Adolescent Medicine, reports results of a study that aimed to better understand vaccine decision-making in low-resource settings in order to identify strategies for successful human …

Author: Bingham A, Drake JK, LaMontagne DS

Publication date: 2009

State of the World's Vaccines and Immunization, Third Edition

This report focuses on the major developments in vaccines and immunization since 2000. Part 1 examines the impact of immunization on efforts to meet the Millennium Development Goals. It looks at the development and use of vaccines and the …

Author: World Health Organization, United Nations Children's Fund, World Bank

Publication date: 2009

The State of Vaccine Confidence: 2015

This report aims to build understanding of the global picture of public confidence in vaccines by analyzing vaccine confidence issues and paths to their resolution over the past decade. It presents options for monitoring and measuring public …

Author: London School of Hygiene & Tropical Medicine

Publication date: 2015

Strategic Planning and Situation Assessment for Cervical Cancer Prevention: Practical Experience from PATH

From 2006 to 2011, PATH conducted demonstration projects in four low- and middle-income countries—India, Peru, Uganda, and Vietnam—to provide evidence for decision-making about public-sector introduction of human papillomavirus (HPV) …

Author: PATH

Publication date: 2011

Strategies for HPV Vaccination in the Developing World

Developing strategies to effectively reach adolescent girls with HPV vaccines—a population not typically the focus of public health programs—is essential to achieving high coverage rates and reducing the cervical cancer burden. This issue brief …

Author: Cervical Cancer Action

Substantial Decline in Vaccine-Type Human Papillomavirus (HPV) Among Vaccinated Young Women During the First 8 Years After HPV Vaccine Introduction in a Community

This article, published in Clinical Infectious Diseases, reports on a series of three short-term surveillance studies that examined the epidemiological impact of human papillomavirus (HPV) vaccine introduction over time. Specifically, the authors …

Author: Kahn JA, Widdice LE, Ding L, et al.

Publication date: 2016

Summary of Vaccine Stability Data

These documents provide stability data as of November 2012 on commonly used, licensed vaccines and stability data as of May 2012 from available data on novel, investigational vaccine formulations. Data are sorted by vaccine in a table format in both …

Author: PATH, Working in Tandem Ltd.

Publication date: 2012

TechNet Resource Library

This website provides an online repository of useful journal articles, documents, tools, websites, and other immunization resources. Users are able to search by keyword or browse the collection by category, disease, or other tag. Members of the …

Author: Technical Network for Strengthening Immunization Services

Too Late to Vaccinate? The Incremental Benefits and Cost-Effectiveness of a Delayed Catch-Up Program Using the 4-Valent Human Papillomavirus Vaccine in Norway

This article, published in the Journal of Infectious Diseases, reports on a study to evaluate the benefits and cost-effectiveness of a delayed, one-year female catch-up human papillomavirus (HPV) vaccine program in Norway. The authors found that …

Author: Burger EA, Sy S, Nygard M, Kristiansen IS, Kim JJ

Publication date: 2015

Toolkit – The Assessment of Adolescent Health Interventions in GAVI HPV Vaccine Demonstration Programmes

This toolkit provides resources to evaluate existing adolescent health interventions in order to prioritize feasible health interventions to be delivered with human papillomavirus (HPV) vaccination. The kit contains tools and templates to guide …

Author: World Health Organization

Publication date: 2013

Two-Dose Schedules for Human Papillomavirus Vaccine: Systematic Review and Meta-Analysis

This article, published in Vaccine, reports the results of a study comparing the effects of a two-dose versus a three-dose immunization schedule for human papillomavirus (HPV) vaccine. According to the evidence systematically reviewed in this study, …

Author: D'Addario M, Redmond S, Scott P, et al.

Publication date: 2017

Unprotected People Reports

This web page contains real-life accounts of people who have suffered or died from vaccine-preventable diseases, including compelling personal testimonies, remembrances, case reports, and newspaper articles.

Author: Immunization Action Coalition

Page 8 of 9